Ritual, ceremony & traditional plant medicine, honestly

Two things are true at once. Ritual and ceremony have real, measurable psychological value — and some traditional plants have led to genuine medicines. But “ancient” and “natural” never mean proven or safe, the ceremonial psychedelics are promising research, not approved treatments, and a few traditional remedies are outright dangerous. We judge the practice, not the label.

Judge the practice, not the label

Ritual, ceremony, sacred plants and traditional medicine get lumped together and then either dismissed as superstition or sold as ancient wisdom. Both are lazy. The honest approach is to pull them apart and ask of each: what does it actually do, and what does the evidence show?

Some of it holds up on its own terms. Some is genuinely promising but still experimental. And some — including a few celebrated “natural” remedies — can seriously harm you. Respect for a tradition and demand for evidence are not in conflict.

Ritual itself has real psychology

You don’t need any drug for this part.

• Ritual regulates emotion, anxiety and social bonding — Across psychology, anthropology and neuroscience, structured ritual — repeated, symbolic actions — helps regulate emotion, steady performance nerves, mark grief and transitions, and bind groups together. The meaning and the predictability do real work, independent of any belief in the supernatural. (emerging)

The ceremonial plants — promising, supervised, unproven

Research-only. Not approved. Cross-links to our psychedelics deep dive.

• Psilocybin (“magic mushrooms”) for depression — In the largest trial, a single supervised 25 mg dose of psilocybin with psychological support reduced treatment-resistant depression versus a low dose — but durable response was limited and adverse events (including suicidal ideation) occurred. Promising, supervised, not approved. (emerging)
• Not clearly better than a standard antidepressant — Head-to-head, psilocybin was not significantly better than the SSRI escitalopram on the main depression measure — a useful reality check against the “miracle mushroom” framing. (emerging)
• Ayahuasca for depression — one small positive trial — A single dose of ayahuasca beat placebo for treatment-resistant depression at one week in a small randomised trial (29 people, frequent vomiting, short follow-up). Intriguing, far from established. (emerging)

The real risks — read before the hype

• Ayahuasca + antidepressants can be life-threatening — Ayahuasca contains MAO-inhibiting harmala alkaloids (from the B. caapi vine) that let its DMT work orally. Combined with SSRIs or other antidepressants, that can trigger serotonin syndrome — potentially fatal. This is a hard pharmacological contraindication, not a caution. (established)
• Not for a history of psychosis or bipolar disorder — Psychedelics can precipitate psychosis or mania in people with a personal or family history — trials screen carefully for exactly this. There is also cardiovascular strain, and ayahuasca’s near-universal vomiting/diarrhoea (“la purga”). (established)
• Unregulated retreats and illegality — Most of these substances are illegal outside research in most countries, and commercial retreats vary wildly in screening and safety, with rare reported deaths. Set, setting, screening and integration are part of the intervention — not decoration you can skip. (note)

Traditional medicine, honestly

Real gifts — and real poisons.

• Traditional knowledge has produced real drugs — The best argument for taking tradition seriously: artemisinin, a first-line malaria drug, came from sweet wormwood guided by an old Chinese text (a 2015 Nobel Prize) — as aspirin traces back to willow bark. Traditional use is a genuine source of leads worth studying. (established)
• “Natural” and “traditional” do not mean safe — The counterweight: some traditional herbs cause serious harm. Aristolochic-acid-containing herbs cause kidney failure and urinary-tract cancer — a proven Group 1 human carcinogen. Contamination, adulteration and toxicity are real; evidence still has to be demanded. (established)

What we still don’t know

• Whether the plant or the ceremony does the work Trial benefit comes bundled with screening, preparation, supervision and integration — how much is the molecule versus the ritual around it is genuinely unresolved.
• How durable and how safe outside trials Effects are short-studied and the real-world safety of retreat and solo use — outside carefully screened trials — is poorly documented.
• Which traditional remedies are worth studying For most, rigorous human evidence simply doesn’t exist yet, and quality/contamination varies enormously — so blanket claims, for or against, aren’t justified.

Key terms

• Ritual A predefined, often repeated and symbolic sequence of actions valued for its psychological or social meaning rather than a direct practical effect.
• Ethnobotany The study of how specific cultures traditionally use plants — as food, medicine and in ceremony.
• Psilocybin The main psychoactive compound in “magic mushrooms”; studied under supervision for depression, not an approved treatment.
• DMT A short-acting psychedelic; inactive when swallowed alone because gut enzymes destroy it — which is why ayahuasca pairs it with an MAO inhibitor.
• MAOI A monoamine-oxidase inhibitor; ayahuasca’s harmala alkaloids act this way, and combining them with antidepressants can cause dangerous serotonin syndrome.
• Ayahuasca A traditional Amazonian brew combining a DMT-containing plant with an MAOI-containing vine, taken in ceremony.
• Set and setting The idea that a psychedelic experience is shaped as much by your mindset (“set”) and environment (“setting”) as by the drug itself.